Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? [electronic resource]
Producer: 20061103Description: 822-9 p. digitalISSN:- 0305-7453
- Adult
- Anti-Bacterial Agents -- administration & dosage
- Cystic Fibrosis -- drug therapy
- Drug Resistance, Bacterial
- Female
- Humans
- Male
- Microbial Sensitivity Tests
- Pseudomonas Infections -- drug therapy
- Pseudomonas aeruginosa -- drug effects
- Respiratory Function Tests
- Tobramycin -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.